|
Business |
|
Cheminor Drugs Ltd (CDL), a Dr Reddy Group company, makes bulk drugs, intermediates and formulations. Exports comprise over 60% of the company�s sales, with US being the largest overseas market with almost 18% share of the turnover. The bulk actives and finished dosage business (the unit is 100% EOU) are focused towards the markets of Europe, Australia, Japan, South Africa and US. The company�s principal products are Ibuprofen, Naproxen and Ran... More.. |
|
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2000(6) | 31-Mar-2000 (12) | 31-Mar-1999 (12) | | Net sales | 1098.00 | 2154.36 | 2151.02 | | Other Income | 112.85 | 128.36 | 91.14 | | Total Income | 1210.85 | 2282.72 | 2242.17 | | Cost of goods sold | 858.37 | 1653.95 | 1747.33 | | OPBDIT | 352.48 | 628.77 | 494.84 | | PAT | 142.91 | 265.06 | 208.96 | | Gross Block | - | 2151.84 | 1566.45 | | Equity capital | 156.34 | 156.34 | 156.34 | | EPS (Rs.) | - | 16.95 | 13.37 | | DPS (Rs.) | - | 3.00 | 3.00 | | BV (Rs.) | - | 83.08 | 76.81 | | P/E range (x) | - | 15.46 - 39.94 | 8.23 - 24.38 | | Debt / Equity (x) | - | 1.41 | 1.33 | | Operating margin (% of OI) | 29.1 | 27.5 | 22.1 | | Net margin (% of OI) | 11.8 | 11.6 | 9.3 |
|
|
Detailed Financials
|
|
|
|
|
